Literature DB >> 36217186

Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic).

Virginia Fernandes Moça Trevisani1,2, Aysa César Pinheiro3, Sonia Cristina de Magalhães Souza Fialho4, Marilena Leal Mesquita Silvestre Fernandes5, Alisson Pugliesi6, Sandra Gofinet Pasoto7, Maria Lucia Lemos Lopes8, Lissiane Karine Noronha Guedes7, Samira Tatiyama Miyamoto9, Laura Caldas Dos Santos10, Simone Appenzeller6, Tania Fidelix10, Sandra Lúcia Euzébio Ribeiro11, Danielle Christinne Soares Egypto de Brito12, Tatiana Nayara Libório-Kimura13, Maria Carmen Lopes Ferreira Silva Santos14, Diego Ustárroz Cantali15, Juliana D 'Agostino Gennari16, Karina Gatz Capobianco17, Vinicius Tassoni Civile1, Ana Carolina Pereira Nunes Pinto1,18, Aline Pereira da Rocha1, César Ramos Rocha-Filho1, Fabiola Reis Oliveira19, Valeria Valim20.   

Abstract

Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.
© 2022. The Author(s).

Entities:  

Keywords:  Clinical guidelines; Gastrointestinal diseases; Sjögren’s syndrome

Mesh:

Year:  2022        PMID: 36217186     DOI: 10.1186/s42358-022-00267-y

Source DB:  PubMed          Journal:  Adv Rheumatol        ISSN: 2523-3106


  82 in total

1.  Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Jose-María Sánchez-Tapias; Albert Parés; Xavier Forns; Pilar Brito-Zerón; Norma Nardi; Pilar Vazquez; Desirée Vélez; Isabel Arias; Albert Bové; Joan Plaza; Juan Rodés; Josep Font
Journal:  J Rheumatol       Date:  2006-08       Impact factor: 4.666

2.  Liver involvement in primary Sjögren's syndrome.

Authors:  F N Skopouli; C Barbatis; H M Moutsopoulos
Journal:  Br J Rheumatol       Date:  1994-08

3.  Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.

Authors:  Norma Nardi; Pilar Brito-Zerón; Manuel Ramos-Casals; Sira Aguiló; Ricard Cervera; Miguel Ingelmo; Josep Font
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

Review 4.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

Review 5.  Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis.

Authors:  Baodong Qin; Jiaqi Wang; Zaixing Yang; Min Yang; Ning Ma; Fenglou Huang; Renqian Zhong
Journal:  Ann Rheum Dis       Date:  2014-06-17       Impact factor: 19.103

6.  Sjögren's syndrome in patients with primary biliary cirrhosis.

Authors:  E V Tsianos; J H Hoofnagle; P C Fox; M Alspaugh; E A Jones; D F Schafer; H M Moutsopoulos
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

7.  Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren's syndrome.

Authors:  Aldo J Montaño-Loza; José Carlos Crispín-Acuña; José María Remes-Troche; Misael Uribe
Journal:  Ann Hepatol       Date:  2007 Jul-Sep       Impact factor: 2.400

8.  Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.

Authors:  Sang-Won Lee; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Jungsik Song; Yong-Beom Park; Soo-Kon Lee; Kwang-Hyub Han; Seung Up Kim
Journal:  Mod Rheumatol       Date:  2016-02-16       Impact factor: 3.023

9.  2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.

Authors:  Caroline H Shiboski; Stephen C Shiboski; Raphaèle Seror; Lindsey A Criswell; Marc Labetoulle; Thomas M Lietman; Astrid Rasmussen; Hal Scofield; Claudio Vitali; Simon J Bowman; Xavier Mariette
Journal:  Arthritis Rheumatol       Date:  2016-10-26       Impact factor: 10.995

10.  The liver is a common non-exocrine target in primary Sjögren's syndrome: a retrospective review.

Authors:  Mariana J Kaplan; Robert W Ike
Journal:  BMC Gastroenterol       Date:  2002-09-13       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.